Relief Therapeutics
Develops innovative treatments for the affections associated with degeneration of the peripheral nervous system (neuropathy)
Geneva, SwitzerlandFounded 2013
Total raised
€16M
€16,479,432
Funding rounds
2
Investors
1
distinct backers
Active since
2016-04
latest 2021-07
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood17
base rate 38% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 13y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-26 | Growth/Late | €14M | — | View deal → |
| 2016-05-01 | Series A | €2.5M | Global Emerging Markets | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy